Lipoprotein Metabolism in Familial Hypercholesterolemia
View/ Open
Date
2021-03-03Author
Chemello, Kevin
García Nafría, Javier
Gallo, Antonio
Martín Plágaro, César Augusto
Lambert, Gilles
Blom, Dirk
Metadata
Show full item record
Journal Of Lipid Research 62 : (2021) // Article ID 100062
Abstract
Familial hypercholesterolemia (FH) is one of the most common genetic disorders in humans. It is an extremely atherogenic metabolic disorder characterized by lifelong elevations of circulating LDL-C levels often leading to premature cardiovascular events. In this review, we discuss the clinical phenotypes of heterozygous and homozygous FH, the genetic variants in four genes (LDLR/APOB/PCSK9/LDLRAP1) underpinning the FH phenotype as well as the most recent invitro experimental approaches used to investigate molecular defects affecting the LDL receptor pathway. In addition, we review perturbations in the metabolism of lipoproteins other than LDL in FH, with a major focus on lipoprotein (a). Finally, we discuss the mode of action and efficacy of many of the currently approved hypocholesterolemic agents used to treat patients with FH, with a special emphasis on the treatment of phenotypically more severe forms of FH